Señales en vivo de ONC.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 10:24):

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally...

Stats
Volumen de hoy	86 635.00
Volumen promedio	74 365.00
Capitalización de mercado	17.05M
EPS	£0 ( 2023-09-28 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.640
ATR14	£0 (0.00%)

Oncimmune Holdings PLC Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncimmune Holdings PLC Finanzas

Annual	2022
Ingresos:	£1.15M
Beneficio Bruto:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Ingresos:	£1.15M
Beneficio Bruto:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Ingresos:	£3.86M
Beneficio Bruto:	£1.46M (37.76 %)
EPS:	£-0.140

FY	2021
Ingresos:	£3.72M
Beneficio Bruto:	£2.86M (76.76 %)
EPS:	£-0.0717

Financial Reports:

No articles found.

Oncimmune Holdings PLC

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.